Technical Analysis for SLP - Simulations Plus, Inc.

Grade Last Price % Change Price Change
D 46.18 -5.02% -2.44
SLP closed down 5.02 percent on Monday, July 1, 2024, on 2.13 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Jul 4
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
MACD Bullish Centerline Cross Bullish -5.02%
Pocket Pivot Bullish Swing Setup -5.02%
Bollinger Band Squeeze Range Contraction -5.02%
BB Squeeze + Upper Band Touch Range Contraction -5.02%

   Recent Intraday Alerts

Alert Time
Gapped Up (Partial) about 11 hours ago
Fell Below 50 DMA about 11 hours ago
Fell Below Previous Day's Low about 11 hours ago
Down 2 % about 11 hours ago
Down 1% about 11 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Simulations Plus, Inc. Description

Simulations Plus, Inc. designs and develops pharmaceutical simulation software for use in the pharmaceutical research and in the education of pharmacy and medical students. The company's products include ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Designer, a molecule drawing program or sketcher; MedChem Studio, a tool for data mining and designing new drug-like molecules by medicinal and computational chemists; DDDPlus, which simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives contained in tablets and capsules; and GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals. It also develops and sells Abbreviate!, a productivity software program, as well as offers consulting and contract research services to the pharmaceutical industry. The company operates in North America, Europe, Asia, and South America. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.


Classification

Sector: Technology
Industry: Health Information Services
Keywords: Health Sciences Pharmacy Pharmacology In Vitro Pharmaceutical Sciences Medicinal Chemistry Lancaster Pharmacokinetics Software Program Simulation Software Contract Research Services Data Mining Pharmaceutical Research Pharmacodynamics

Is SLP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 52.4456
52 Week Low 32.7665
Average Volume 88,314
200-Day Moving Average 42.44
50-Day Moving Average 47.65
20-Day Moving Average 47.19
10-Day Moving Average 47.53
Average True Range 1.50
RSI (14) 43.18
ADX 12.65
+DI 24.35
-DI 26.84
Chandelier Exit (Long, 3 ATRs) 45.62
Chandelier Exit (Short, 3 ATRs) 48.97
Upper Bollinger Bands 49.18
Lower Bollinger Band 45.19
Percent B (%b) 0.25
BandWidth 8.46
MACD Line -0.05
MACD Signal Line -0.03
MACD Histogram -0.0264
Fundamentals Value
Market Cap 922.08 Million
Num Shares 20 Million
EPS 0.53
Price-to-Earnings (P/E) Ratio 87.13
Price-to-Sales 13.33
Price-to-Book 4.81
PEG Ratio 9.77
Dividend 0.24
Dividend Yield 0.52%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.63
Resistance 3 (R3) 51.10 50.07 49.89
Resistance 2 (R2) 50.07 48.94 49.84 49.64
Resistance 1 (R1) 48.13 48.24 47.61 47.66 49.40
Pivot Point 47.10 47.10 46.85 46.87 47.10
Support 1 (S1) 45.16 45.97 44.65 44.70 42.96
Support 2 (S2) 44.13 45.27 43.90 42.72
Support 3 (S3) 42.19 44.13 42.47
Support 4 (S4) 41.73